Shilpa Medicare Q2 profit rises 80% to ₹79 crore
In short
Shilpa Medicare reported Q2 net profit of ₹79 crore, up 80% from a year earlier. Revenue rose 43% to ₹529 crore.
The company said new customer wins in the US and Japan, plus peptide expansion and planned European CDMO supplies, are expected to support growth later on.
What the reporting says
Shilpa Medicare reported an 80% year-on-year jump in Q2 net profit to ₹79 crore, while revenue rose 43% to ₹529 crore. The company cited new customer wins in the US and Japan, peptide expansion and upcoming European CDMO supplies as support for FY27 growth. The results point to stronger operating performance and a growth pipeline.
Why it matters
Shilpa Medicare reported Q2 net profit of ₹79 crore, up 80% year on year, and revenue of ₹529 crore, up 43%. The company pointed to new customer wins in the US and Japan, peptide expansion and upcoming European CDMO supplies as growth drivers for FY27. The earnings beat signals improved business momentum in its pharma operations.